Jefferies Top 2025 Stock Picks Include 5 Sizzling Large Cap Dividend Blue Chips24/7 Wall Street • 01/03/25
Gilead Sciences Stock Today: Boost Your Return With This Covered Call TradeInvestors Business Daily • 12/23/24
Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold?Zacks Investment Research • 12/20/24
GILD's Trodelvy Gets Second Breakthrough Therapy Tag for Lung CancerZacks Investment Research • 12/18/24
U.S. FDA Grants Breakthrough Therapy Designation to Trodelvy® (sacituzumab govitecan-hziy) for Second-Line Treatment of Extensive-Stage Small Cell Lung CancerBusiness Wire • 12/17/24
Gilead and Terray Therapeutics Announce Multi-Target Research Collaboration to Discover and Develop Novel Small Molecule TherapiesBusiness Wire • 12/17/24
Gilead's Seladelpar Receives Positive CHMP Opinion for Primary Biliary CholangitisBusiness Wire • 12/13/24
Kite's Yescarta® Only CAR T-Cell Therapy to Show Durable Response and Long-Term Survival After Five Years in Patients With Relapsed/Refractory Non-Hodgkin Lymphomas at ASH 2024Business Wire • 12/09/24
Longest Follow-Up Data Reported for Kite's Tecartus® CAR T-Cell Therapy at ASH 2024 Reinforce Durable Efficacy and Survival BenefitsBusiness Wire • 12/09/24
Kite Presents New Data Underscoring Curative Potential of Yescarta® in Relapsed/Refractory Large B-cell Lymphoma at ASHBusiness Wire • 12/08/24
Gilead Sciences, Inc. (GILD) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)Seeking Alpha • 12/04/24
Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADCZacks Investment Research • 12/04/24
Gilead Sciences, Inc. (GILD) Piper Sandler 36th Annual Healthcare Conference (Transcript)Seeking Alpha • 12/03/24